Literature DB >> 17173238

Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B.

Valdir Sabbaga Amato, Felipe Francisco Tuon, Aleia Campos, Helio Arthur Bacha, Antonio Carlos Nicodemo, Vicente Amato Neto, Maria Aparecida Shikanai-Yasuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17173238     DOI： 10.1086/510494

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

Review 1.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

Review 2.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

3.  Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis.

Authors:  Regina Maia de Souza; Raul Cavalcante Maranhão; Elaine Rufo Tavares; Fabíola Branco Filippin-Monteiro; Antônio Carlos Nicodemo; Aleksandra Tiemi Morikawa; Edite Hatsumi Yamashiro Kanashiro; Valdir Sabbaga Amato
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

4.  Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.

Authors:  Mirella A Cunha; Aline C Q Leão; Rita de Cassia Soler; José Angelo L Lindoso
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

Review 5.  Liposomal drug delivery systems for the treatment of leishmaniasis.

Authors:  Felipe Francisco Tuon; Leticia Ramos Dantas; Regina Maia de Souza; Victoria Stadler Tasca Ribeiro; Valdir Sabbaga Amato
Journal:  Parasitol Res       Date:  2022-09-16       Impact factor: 2.383

6.  Case Report: Mucocutaneous Leishmaniasis Masquerading as Idiopathic Midline Granulomatous Disease.

Authors:  Nilesh Tejura; Eunjung Kim; Lisa L Dever; Debra Chew
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

7.  Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.

Authors:  Felipe F Tuon; Giovana Marina Bombonatto; Eveline Roesler Battaglin; Marcus Henrique Sakumoto; Valdir Sabbaga Amato; Raphael Abegão de Camargo; Antônio Carlos Nicodemo
Journal:  Am J Trop Med Hyg       Date:  2014-04-14       Impact factor: 2.345

8.  Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.

Authors:  Carolina Rocio Santos; Felipe Francisco Tuon; Juliette Cieslinski; Regina Maia de Souza; Rui Imamura; Valdir Sabbaga Amato
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.